Product Name |
Catalog Number |
CAS Number |
MSDS |
(2R,3R,4S,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
|
NVC023602 |
41552-82-3 |
MSDS |
MLCK inhibitor peptide 18
|
NVC023603 |
224579-74-2 |
MSDS |
11-[2-[4-[4-(diethylamino)butyl]piperidin-1-yl]acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
|
NVC023604 |
123548-16-3 |
MSDS |
4-[4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)imidazol-1-yl]cyclohexan-1-ol
|
NVC023605 |
193551-21-2 |
MSDS |
1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide
|
NVC023606 |
85532-75-8 |
MSDS |
clobenpropit
|
NVC023607 |
145231-45-4 |
MSDS |
cyclothiazide
|
NVC023608 |
2259-96-3 |
MSDS |
[acetyl-(4-chlorophenyl)sulfonylamino] acetate
|
NVC023609 |
142867-52-5 |
MSDS |
N-[4,6,8-tris(methylsulfonyl)naphthalen-1-yl]-4-[[4-[[4-[[4-[[4,6,8-tris(methylsulfonyl)naphthalen-1-yl]carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzamide
|
NVC023610 |
202983-32-2 |
MSDS |
1-(3,6-dibromocarbazol-9-yl)-3-piperazin-1-ylpropan-2-ol,dihydrochloride
|
NVC023611 |
335165-68-9 |
MSDS |
cis-4-(phosphonomethyl)-2-piperidinecarboxylic acid
|
NVC023612 |
110347-85-8 |
MSDS |
[(E)-4-amino-5-ethoxy-2-methyl-5-oxopent-2-enyl]phosphonic acid
|
NVC023613 |
127910-32-1 |
MSDS |
β-Funaltrexamine hydrochloride,(E)-4-[[5α,6β)-17-Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-2-butenoicacidmethylesterhydrochloride
|
NVC023614 |
72786-10-8 |
MSDS |
FR 122047 hydrochloride,1-[[4,5-bis(4-Methoxyphenyl)-2-thiazolyl]carbonyl]-4-methylpiperazinehydrochloride
|
NVC023615 |
130717-51-0 |
MSDS |
2-[3-[(4-bromo-2-fluorophenyl)methyl]-4-oxophthalazin-1-yl]acetic acid
|
NVC023616 |
72702-95-5 |
MSDS |